טוען...
Immunogenicity associated with metreleptin treatment in patients with obesity or lipodystrophy
OBJECTIVE: Recombinant human leptin (metreleptin) improves glycemia and hypertriglyceridemia in patients with generalized lipodystrophy; antibody development with in vitro neutralizing activity has been reported. We aimed to characterize anti-metreleptin antibody development, including in vitro neut...
שמור ב:
| הוצא לאור ב: | Clin Endocrinol (Oxf) |
|---|---|
| Main Authors: | , , , , , , |
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
2016
|
| נושאים: | |
| גישה מקוונת: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4875885/ https://ncbi.nlm.nih.gov/pubmed/26589105 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/cen.12980 |
| תגים: |
הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|